跳至主要内容
临床试验/JPRN-UMIN000013799
JPRN-UMIN000013799招募中未知

Safety and efficacy of live attenuated varicella vaccine for preventing varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation: A Prospective Single-Center Study - Live attenuated varicella vaccine after allogeneic HSCT

Division of Hematology, Saitama Medical Center, Jichi Medical University0 个研究点目标入组 31 人开始时间: 2014年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who have a serious active infection 2) Patients who have a high fever above 37.5 degrees when they receive vaccination 3) Patients who have severe acute illness 4) Patients who experienced an anaphylactic shock due to vaccinations 5) Patients who are or may be pregnant 6) Patients with serious mental disorder 7) Patients who developed VZV disease after allogeneic HSCT 8) Patients with VZV-seronegative before allogeneic HSCT 9) Patients who received inactivated vaccine within 1 week or other live attenuated vaccine within 4 weeks 10) Patients who received transfusions or gamma globulin

研究者

发起方
Division of Hematology, Saitama Medical Center, Jichi Medical University

相似试验

Safety and efficacy of live attenuated varicella... | 临床试验